Status: Not yet recruiting
Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia
A study to evaluate the safety, tolerability, and preliminary efficacy of DS010 in patients with cancer and cachexia
Participants needed: 58
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Dartsbio Pharmaceuticals Ltd.Updated: Apr 15, 2026Locations: 1
Eligibility criteria
Subjects aged ≥ 18 years at screening; [+5]
History of hypersensitivity or anaphylactic reaction to any therapeutic or diagn... [+5]